Strokes are the fifth leading cause of death, according to the American Stroke Association and they're also a leading cause of disability across the U.S. Dr. Reade De Leacy, a neurosurgery specialist, joined Cheddar News to talk about the importance of response time when treating patients that have suffered strokes. "In stroke, especially in major stroke, two million brain cells are lost for every minute of delay in treatment so time really, really critical," he said.
The United States is approaching a record for the number of new daily coronavirus cases in the latest ominous sign of the disease’s grip on the nation.
A pilot study from New York University found that over the summer a quarter of NYC transit workers reported testing positive for the coronavirus and that 90 percent of them still had fears of contracting COVID-19 on the job.
Justice Department officials told The Associated Press that Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion.
Following psychedelic medicine company, COMPASS Pathways' IPO on the Nasdaq in September,.George Goldsmith, CEO and co-founder, joined Cheddar to discuss using psychedelics to innovate mental health treatments.
Katie Couric and the CEO of Susan G. Komen join Cheddar to discuss the importance of preventative healthcare and support resources during Breast Cancer Awareness Month.
Pharmaceutical company Merck has partnered with drone startup Volansi to make remote vaccine deliveries. Hannan Parvizian, Volansi founder and CEO, joined Cheddar to discuss the partnership and supplying rural areas with temperature-controlled vaccines..
The world's number of confirmed cases of COVID-19 has surpassed 40 million.
Nokia says it has been tapped by NASA to build the first cellular communications network on the moon.
Christian Gormsen, Eargo CEO, joined Cheddar to discuss the hearing aid company going public. and also about the path to expanding insurance coverage to include hearing aids.
Pfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well.
